Citigroup’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Citigroup’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,000	Closed	-$1K	–	7520
2016 Q3	$1K	Buy	+2,000	New	+$1K	﹤0.01%	7028

Citigroup's RXII Position: Q4 2016 in Review

Citigroup sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 30,071 shares — an estimated $11K sold.

Citigroup first reported a position in RXII in Q2 2013 and held it in 14 quarters. The position peaked at $278K in Q4 2013. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Citigroup reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Citigroup sold 30,071 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $11K.
Citigroup first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 14 quarters.
Citigroup's GALENA BIOPHARMA INC COM position peaked at $278K in Q4 2013.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Citigroup's 13F filing for Q4 2016, filed 10 Feb 2017.